Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00439257 · ClinicalTrials.gov registry record
Costs, Quality of Life and Functional Outcomes in Veterans Treated for Multiple Sclerosis With Beta-Interferon l-B (Betaseron)
A clinical trial, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- 124
- Enrollment target
NCT00439257 is a clinical trial that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 124 participants.
The verdict
NCT00439257 has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- 124 participants
- Enrollment target
Study Summary
The treatment of multiple sclerosis was evolving in light of specific drug therapies to treat the disease, refinements and acceptance of imaging with MRI to diagnose and monitor the disease process, and progress in understanding the pathogenesis of the inflammatory demyelinating process. The result was to raise new issues in the treatment of the disease, which are then being addressed by studies, including when to initiate treatment and the treatment of partial responders to existing therapies. Paralleling strides in treatment, and of particular importance to the Veterans Administration, was the effectiveness of such therapies, both in terms of cost to the VA Health Care System and quality of life of veterans with multiple sclerosis. This study addressed these issues.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Est. Completion | 2000-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00439257
The ClinicalTrials.gov registry entry for NCT00439257 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00439257 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00439257 about?
NCT00439257 is a clinical study titled "Costs, Quality of Life and Functional Outcomes in Veterans Treated for Multiple Sclerosis With Beta-Interferon l-B (Betaseron)". The treatment of multiple sclerosis was evolving in light of specific drug therapies to treat the disease, refinements and acceptance of imaging with MRI to diagnose and monitor the disease process, and progress in understanding the pathogenesis of the inflammatory demyelinating process. The result ...
What is the current status of trial NCT00439257?
This trial is currently completed. The enrollment target is 124 participants. Estimated completion is 2000-06.
Who is sponsoring clinical trial NCT00439257?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.